Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: axial spondyloarthritis

Andrew Brookes / Image Source on Offset

Clinical Insights into Axial Spondyloarthritis: Rheumatology Drugs at a Glance, Part 5

Mary Choy, PharmD, BCGP, FASHP  |  February 10, 2022

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options; others have few or only off-label options. This series, Rheumatology Drugs at a Glance, provides streamlined information on the administration of biologic, biosimilar and other medications used to…

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug Updates Tagged with:Ankylosing SpondylitisAS Resource Center

MRI & Axial Spondyloarthritis: Experts Discuss Controversies in the Diagnostic Evaluation of axSpA

Lara C. Pullen, PhD  |  January 25, 2021

Three experts discuss the ins and outs of using magnetic resonance imaging to diagnose axial spondyloarthritis, particularly in individuals who lack clear clinical symptoms indicative of disease.

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting Reports Tagged with:ACR Convergence 2020Ankylosing SpondylitisAS Resource Centeraxial spondyloarthritis (SpA)

Chu KyungMin / shutterstock.com

Axial Spondyloarthritis FocusRheum

Axial spondyloarthritis (axSpA), comprising ankylosing spondylitis (AS) and nonradiographic axial SpA, is the main form of chronic inflammatory arthritis affecting the axial skeleton. In this resource center, you’ll find Dr. David Pisetsky’s picks for the top research in axSpA presented at ACR Convergence 2024 our summary of the 2019 treatment guideline, as well as current…

Non-Radiographic Axial Spondyloarthritis Recognized with ICD-10 Code

Larry Beresford  |  August 21, 2020

The new diagnostic code should streamline billing for treatment of nr-axSpA, better define the spectrum of spondyloarthritic diseases and enable new research strategies into these conditions.

Filed under:Axial SpondyloarthritisBilling/Coding Tagged with:Committee on Rheumatologic Care (CORC)ICD-10non-radiographic axial spondyloarthritis

FDA Approves Secukinumab for Non-Radiographic Axial Spondyloarthritis

Michele B. Kaufman, PharmD, BCGP  |  August 5, 2020

In June, the FDA approved secukinumab to treat non-radiographic axial spondyloarthritis after data from a clinical trial demonstrated its efficacy…

Filed under:Drug Updates Tagged with:FDAFDA approvalnon-radiographic axial spondyloarthritissecukinumabU.S. Food and Drug Administration (FDA)

Clinical Pearls: What We Know About Nonradiographic Axial Spondyloarthritis

Jason Liebowitz, MD, FACR  |  June 16, 2020

ACR BEYOND LIVE—Much, if not all, of rheumatology relies on clinical interpretation of historical, laboratory and imaging information to formulate a coherent diagnosis and treatment plan—even when such information is incomplete or has multiple possible interpretations. One of the best examples of this situation pertains to nonradiographic axial spondyloarthritis (nr-axSpA), a condition that is just…

Filed under:Axial SpondyloarthritisConditions Tagged with:ACR State-of-the-Art Clinical Symposiumcriterianon-radiographic axial spondyloarthritis

Axial Spondyloarthritis & Exercise: Should axSpA Patients Exercise?

Mike Fillon  |  March 23, 2020

Two experts weigh in on whether & how axial spondyloarthritis patients should exercise…

Filed under:Axial SpondyloarthritisConditions Tagged with:2019 ACR/ARP Annual Meetingaxial spondyloarthritis (SpA)ExerciseExercise/physical therapy

From Chronic Low Back Pain to Axial Spondyloarthritis

Mike Fillon  |  February 13, 2020

ATLANTA—Research into possible genetic drivers of the axial spondyloarthritis (axSpA), including the role of the genetic marker HLA-B27, is advancing, John D. Reveille, MD, professor and vice chair of medicine at the University of Texas McGovern Medical School, Houston, told attendees at the 2019 ACR/ARP Annual Meeting. Dr. Reveille delivered the Philip Hench, MD, Memorial…

Filed under:Axial SpondyloarthritisConditionsMeeting Reports Tagged with:2019 ACR/ARP Annual Meetingaxial spondyloarthritis (SpA)chronic low-back painHLA-B27

Phase 3 Results for Ixekizumab Promising in Patients with Non-Radiographic Axial Spondyloarthritis

Michele B. Kaufman, PharmD, BCGP  |  January 6, 2020

In a phase 3 study, ixekizumab proved safe and effective for improving the signs and symptoms of non-radiographic axial spondyloarthritis (axSpA) in combination with conventional background medications, such as NSAIDs…

Filed under:Drug Updates Tagged with:2019 ACR/ARP Annual Meetingaxial spondyloarthritis (SpA)ixekizumabnon-radiographic axial spondyloarthritis

Updates to Axial Spondyloarthritis Guideline

Carina Stanton  |  September 5, 2019

A 2019 update of the ACR’s previous clinical practice guideline on axial spondyloarthritis is now available online. Lead investigator Michael Ward, MD, shares advice for implementing the guideline updates, including those related to sequencing and tapering biologics, and knowing when to obtain images.

Filed under:Axial SpondyloarthritisClinical Criteria/Guidelines Tagged with:Ankylosing SpondylitisAS Resource Centeraxial spondyloarthritis (SpA)Clinical GuidelinesMichael Ward

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 19
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences